Login to Your Account

FDA's postmarket safety reports rule for combo products 'confusing'

By Liz Hollis
Staff Writer

Thursday, December 22, 2016

Despite industry confusion and concerns, the FDA has unveiled a long-anticipated final rule designed to create consistent, complete postmarket safety reporting requirements for combination products.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription